A Three-Part, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Four-Arm, DiscontinuationStudy to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self Administered byAdults With Phenylketonuria (Prism Study 302)